AKT1 and ovarian carcinoma: DNAJB6a can bind to the phosphorylation sites threonine 308 (T308) and serine 473 (S473) of AKT1, inhibiting AKT1 activation [33], although this signaling pathway may need further investigation in ovarian cancer cells.